+Open data
-Basic information
Entry | Database: EMDB / ID: EMD-50500 | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Title | Expanded formalin inactivated CVB1 | |||||||||||||||
Map data | Density map of expanded formalin inactivated CVB1 resolved at 3 A. | |||||||||||||||
Sample |
| |||||||||||||||
Keywords | coxsackievirus B1 / vaccine / formalin / VIRUS | |||||||||||||||
Function / homology | Function and homology information symbiont-mediated suppression of host cytoplasmic pattern recognition receptor signaling pathway via inhibition of RIG-I activity / picornain 2A / symbiont-mediated suppression of host mRNA export from nucleus / symbiont genome entry into host cell via pore formation in plasma membrane / picornain 3C / T=pseudo3 icosahedral viral capsid / host cell cytoplasmic vesicle membrane / endocytosis involved in viral entry into host cell / nucleoside-triphosphate phosphatase / channel activity ...symbiont-mediated suppression of host cytoplasmic pattern recognition receptor signaling pathway via inhibition of RIG-I activity / picornain 2A / symbiont-mediated suppression of host mRNA export from nucleus / symbiont genome entry into host cell via pore formation in plasma membrane / picornain 3C / T=pseudo3 icosahedral viral capsid / host cell cytoplasmic vesicle membrane / endocytosis involved in viral entry into host cell / nucleoside-triphosphate phosphatase / channel activity / monoatomic ion transmembrane transport / DNA replication / RNA helicase activity / symbiont-mediated activation of host autophagy / RNA-directed RNA polymerase / viral RNA genome replication / cysteine-type endopeptidase activity / RNA-dependent RNA polymerase activity / : / DNA-templated transcription / host cell nucleus / virion attachment to host cell / structural molecule activity / ATP hydrolysis activity / proteolysis / RNA binding / ATP binding / membrane / metal ion binding Similarity search - Function | |||||||||||||||
Biological species | Coxsackievirus B1 | |||||||||||||||
Method | single particle reconstruction / cryo EM / Resolution: 3.01 Å | |||||||||||||||
Authors | Plavec Z / Butcher SJ | |||||||||||||||
Funding support | Finland, 4 items
| |||||||||||||||
Citation | Journal: Res Sq / Year: 2024 Title: Comparison of structure and immunogenicity of CVB1-VLP and inactivated CVB1 vaccine candidates. Authors: Saana Soppela / Zlatka Plavec / Stina Gröhn / Minne Jartti / Sami Oikarinen / Mira Laajala / Varpu Marjomaki / Sarah J Butcher / Minna M Hankaniemi Abstract: Coxsackievirus B1 (CVB1) is a common cause of acute and chronic myocarditis, dilated cardiomyopathy and aseptic meningitis. However, no CVB-vaccines are available for human use. In this study, we ...Coxsackievirus B1 (CVB1) is a common cause of acute and chronic myocarditis, dilated cardiomyopathy and aseptic meningitis. However, no CVB-vaccines are available for human use. In this study, we investigated the immunogenicity of virus-like particle (VLP) and inactivated whole-virus vaccines for CVB1 when administrated to mice via either subcutaneous or intranasal routes formulated with and without commercial and experimental adjuvants. Here, the potential of utilizing epigallocatechin-3-gallate (EGCG) as a mucosal adjuvant synergistically with its ability to inactivate the virus were investigated. EGCG had promising adjuvant properties for CVB1-VLP when administered via the parenteral route but limited efficacy via intranasal administration. However, intranasal administration of the formalin-inactivated virus induced high CVB1-specific humoral, cellular, and mucosal immune responses. Also, based on CVB1-specific IgG-antibody responses, we conclude that CVB1-VLP can be taken up by immune cells when administrated intranasally and further structural engineering for the VLP may increase the mucosal immunogenicity. The preparations contained mixtures of compact and expanded A particles with 85% expanded in the formalin-inactivated virus, but only 52% in the VLP observed by cryogenic electron microscopy. To correlate the structure to immunogenicity, we solved the structures of the CVB1-VLP and the formalin-inactivated CVB1 virus at resolutions ranging from 2.15 A to 4.1 A for the expanded and compact VLP and virus particles by image reconstruction. These structures can be used in designing mutations increasing the stability and immunogenicity of CVB1-VLP in the future. Overall, our results highlight the potential of using formalin inactivated CVB1 vaccine in mucosal immunization programs and provide important information for future development of VLP-based vaccines against all enteroviruses. | |||||||||||||||
History |
|
-Structure visualization
Supplemental images |
---|
-Downloads & links
-EMDB archive
Map data | emd_50500.map.gz | 173.6 MB | EMDB map data format | |
---|---|---|---|---|
Header (meta data) | emd-50500-v30.xml emd-50500.xml | 17.2 KB 17.2 KB | Display Display | EMDB header |
FSC (resolution estimation) | emd_50500_fsc.xml | 14.9 KB | Display | FSC data file |
Images | emd_50500.png | 70 KB | ||
Filedesc metadata | emd-50500.cif.gz | 5.7 KB | ||
Others | emd_50500_half_map_1.map.gz emd_50500_half_map_2.map.gz | 322.9 MB 322.9 MB | ||
Archive directory | http://ftp.pdbj.org/pub/emdb/structures/EMD-50500 ftp://ftp.pdbj.org/pub/emdb/structures/EMD-50500 | HTTPS FTP |
-Validation report
Summary document | emd_50500_validation.pdf.gz | 1.3 MB | Display | EMDB validaton report |
---|---|---|---|---|
Full document | emd_50500_full_validation.pdf.gz | 1.2 MB | Display | |
Data in XML | emd_50500_validation.xml.gz | 24.5 KB | Display | |
Data in CIF | emd_50500_validation.cif.gz | 31.8 KB | Display | |
Arichive directory | https://ftp.pdbj.org/pub/emdb/validation_reports/EMD-50500 ftp://ftp.pdbj.org/pub/emdb/validation_reports/EMD-50500 | HTTPS FTP |
-Related structure data
Related structure data | 9fjeMC 9fjcC 9fjdC M: atomic model generated by this map C: citing same article (ref.) |
---|---|
Similar structure data | Similarity search - Function & homologyF&H Search |
-Links
EMDB pages | EMDB (EBI/PDBe) / EMDataResource |
---|---|
Related items in Molecule of the Month |
-Map
File | Download / File: emd_50500.map.gz / Format: CCP4 / Size: 347.6 MB / Type: IMAGE STORED AS FLOATING POINT NUMBER (4 BYTES) | ||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Annotation | Density map of expanded formalin inactivated CVB1 resolved at 3 A. | ||||||||||||||||||||||||||||||||||||
Projections & slices | Image control
Images are generated by Spider. | ||||||||||||||||||||||||||||||||||||
Voxel size | X=Y=Z: 0.97 Å | ||||||||||||||||||||||||||||||||||||
Density |
| ||||||||||||||||||||||||||||||||||||
Symmetry | Space group: 1 | ||||||||||||||||||||||||||||||||||||
Details | EMDB XML:
|
-Supplemental data
-Half map: Half map of expanded formalin inactivated CVB1.
File | emd_50500_half_map_1.map | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Annotation | Half map of expanded formalin inactivated CVB1. | ||||||||||||
Projections & Slices |
| ||||||||||||
Density Histograms |
-Half map: Half map of expanded formalin inactivated CVB1.
File | emd_50500_half_map_2.map | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Annotation | Half map of expanded formalin inactivated CVB1. | ||||||||||||
Projections & Slices |
| ||||||||||||
Density Histograms |
-Sample components
-Entire : Coxsackievirus B1
Entire | Name: Coxsackievirus B1 |
---|---|
Components |
|
-Supramolecule #1: Coxsackievirus B1
Supramolecule | Name: Coxsackievirus B1 / type: virus / ID: 1 / Parent: 0 / Macromolecule list: all Details: Coxsackievirus B1 (CVB1-10796, isolated from Argentina) NCBI-ID: 12071 / Sci species name: Coxsackievirus B1 / Virus type: VIRION / Virus isolate: OTHER / Virus enveloped: No / Virus empty: Yes |
---|---|
Host (natural) | Organism: Homo sapiens (human) |
Virus shell | Shell ID: 1 / Name: capsid |
-Macromolecule #1: Capsid protein VP1
Macromolecule | Name: Capsid protein VP1 / type: protein_or_peptide / ID: 1 / Number of copies: 1 / Enantiomer: LEVO |
---|---|
Source (natural) | Organism: Coxsackievirus B1 |
Molecular weight | Theoretical: 25.013381 KDa |
Sequence | String: SRSESSIENF LCRSACVYYA TYTNNSKKGF AEWVINTRQV AQLRRKLELF TYLRFDLELT FVITSAQQPS TASSVDAPVQ THQIMYVPP GGPVPTKVKD YAWQTSTNPS VFWTEGNAPP RMSIPFISIG NAYSCFYDGW TQFSRNGVYG INTLNNMGTL Y MRHVNEAG ...String: SRSESSIENF LCRSACVYYA TYTNNSKKGF AEWVINTRQV AQLRRKLELF TYLRFDLELT FVITSAQQPS TASSVDAPVQ THQIMYVPP GGPVPTKVKD YAWQTSTNPS VFWTEGNAPP RMSIPFISIG NAYSCFYDGW TQFSRNGVYG INTLNNMGTL Y MRHVNEAG QGPIKSTVRI YFKPKHVKAW VPRPPRLCQY EKQKNVNFSP IGVTTSRTDI IT UniProtKB: Genome polyprotein |
-Macromolecule #2: Capsid protein VP2
Macromolecule | Name: Capsid protein VP2 / type: protein_or_peptide / ID: 2 / Number of copies: 1 / Enantiomer: LEVO |
---|---|
Source (natural) | Organism: Coxsackievirus B1 |
Molecular weight | Theoretical: 27.71035 KDa |
Sequence | String: RVRSITLGNS TITTQECNNV VVGYGVWPEY LKDNEATAED QPTQPDVATC RFYTLESVQW MKNSAGWWWK LPDALSQMGL FGQNMQYHY LGRTGYTIHV QCNASKFHQG CLLVVCVPEA EMGCSNLNNT PEFSELSGGD SARMFTDTQV GESNAKKVQT A VWNAGMGV ...String: RVRSITLGNS TITTQECNNV VVGYGVWPEY LKDNEATAED QPTQPDVATC RFYTLESVQW MKNSAGWWWK LPDALSQMGL FGQNMQYHY LGRTGYTIHV QCNASKFHQG CLLVVCVPEA EMGCSNLNNT PEFSELSGGD SARMFTDTQV GESNAKKVQT A VWNAGMGV GVGNLTIFPH QWINLRTNNS ATLVMPYINS VPMDNMFRHN NLTLMIIPFV PLNYSEGSSP YVPITVTIAP MC AEYNGLR LA UniProtKB: Genome polyprotein |
-Macromolecule #3: Capsid protein VP3
Macromolecule | Name: Capsid protein VP3 / type: protein_or_peptide / ID: 3 / Number of copies: 1 / Enantiomer: LEVO |
---|---|
Source (natural) | Organism: Coxsackievirus B1 |
Molecular weight | Theoretical: 25.545963 KDa |
Sequence | String: GLPVMTTPGS TQFLTSDDFQ SPSAMPQFDV TPEMQIPGRV NNLMEIAEVD SVVPVNNTED NVSSLKAYQI PVQSNSDNGK QVFGFPLQP GANNVLNRTL LGEILNYYTH WSGSIKLTFM FCGSAMATGK FLLAYSPPGA GVPKNRKDAM LGTHVIWDVG L QSSCVLCV ...String: GLPVMTTPGS TQFLTSDDFQ SPSAMPQFDV TPEMQIPGRV NNLMEIAEVD SVVPVNNTED NVSSLKAYQI PVQSNSDNGK QVFGFPLQP GANNVLNRTL LGEILNYYTH WSGSIKLTFM FCGSAMATGK FLLAYSPPGA GVPKNRKDAM LGTHVIWDVG L QSSCVLCV PWISQTHYRY VVEDEYTAAG YVTCWYQTNI VVPADVQSSC DILCFVSACN DFSVRMLKDT PFIR UniProtKB: Genome polyprotein |
-Experimental details
-Structure determination
Method | cryo EM |
---|---|
Processing | single particle reconstruction |
Aggregation state | particle |
-Sample preparation
Buffer | pH: 7.5 |
---|---|
Grid | Model: Quantifoil R1.2/1.3 / Material: COPPER / Mesh: 300 / Support film - Material: CARBON / Support film - topology: CONTINUOUS / Support film - Film thickness: 200 / Pretreatment - Type: GLOW DISCHARGE / Pretreatment - Time: 10 sec. |
Vitrification | Cryogen name: ETHANE / Chamber humidity: 85 % / Chamber temperature: 295 K / Instrument: LEICA EM GP |
-Electron microscopy
Microscope | FEI TALOS ARCTICA |
---|---|
Image recording | Film or detector model: FEI FALCON III (4k x 4k) / Detector mode: COUNTING / Average electron dose: 40.0 e/Å2 |
Electron beam | Acceleration voltage: 200 kV / Electron source: FIELD EMISSION GUN |
Electron optics | Illumination mode: FLOOD BEAM / Imaging mode: BRIGHT FIELD / Nominal defocus max: 2.8000000000000003 µm / Nominal defocus min: 0.1 µm / Nominal magnification: 150000 |
Experimental equipment | Model: Talos Arctica / Image courtesy: FEI Company |